Abstract
Therapeutic and adverse effects of three dosages (1, 20 and 100 mg daily) of flutroline, a new γ-carboline with a preclinical pharmacological profile similar to active neuroleptic agents, were compared in a double-blind clinical trial in 25 newly-admitted schizophrenic patients. Therapeutic effects and extrapyramidal signs were seen at the 20 and 100-mg daily dosages, but not at the 1-mg dosage. Serum prolactin levels were significantly elevated only at the 100-mg daily dose.
Original language | English (US) |
---|---|
Pages (from-to) | 318-324 |
Number of pages | 7 |
Journal | Unknown Journal |
Volume | 15 |
Issue number | 5 |
DOIs | |
State | Published - Jan 1 1980 |
Externally published | Yes |
ASJC Scopus subject areas
- Medicine(all)